* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 10 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 13 cents per share.
* Revenue rose 4,317.3% to $574.25 thousand from a year ago;
analysts expected zero.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 10 cents.
* The mean earnings estimate of analysts had risen by
about 10.3%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Aethlon Medical Inc shares had risen by 1.9% this
quarter and
gained 41.5% so far this year.
* The company reported a quarterly loss of $2.47 million.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $7.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data June
28 at 10:11 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.13 -0.10 Beat
Dec. 31 2022 -0.08 -0.12 Missed
Sep. 30 2022 -0.21 -0.18 Beat
Jun. 30 2022 -0.22 -0.19 Beat